P16, consisting of an alternative reading frame of cyclin-dependent kinase inhibitor 2A (CDKN2A), is thought to function as a tumor suppressor by negatively regulating the cell cycle and inhibiting cell proliferation [14, 15]. This evidence concerns the gene CDKN2A and neoplasm.